Describing Treatment Outcomes and Responses in Lymphoma-associated Hemophagocytic Lymphohistiocytosis
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The purpose of the study is to describe Hemophagocytic lymphohistiocytosis (HLH) in patients with lymphoma to identify possible therapeutic strategies to improve overall survival of the patients with lymphoma associated hemophagocytic lymphohistiocytosis.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Patients with lymphoma that are fulfilling at least one of the following:
⁃ A. Meeting 5 of 8 HLH-2004 diagnostic criteria OR B. Are OHI index positive (sCD25\>3,900 U/mL and ferritin\>1,000 ng/mL)
Locations
United States
Alabama
University of Alabama at Birmingham
RECRUITING
Birmingham
Contact Information
Primary
Gaurav Goyal, MD
ggoyal@uabmc.edu
205-934-1816
Time Frame
Start Date: 2023-05-01
Estimated Completion Date: 2026-07
Participants
Target number of participants: 2000
Treatments
Hemophagocytic lymphohistiocytosis (HLH) Patients
Related Therapeutic Areas
Sponsors
Leads: University of Alabama at Birmingham